• sagi habasov
  • •
  • 4 Min Read
  • •
  • 12 hours ago

SKN | Can Aytu BioPharma’s Q4 Results Clarify Its Path Beyond Continued Losses?

Aytu BioPharma is set to release its fiscal fourth-quarter 2026 results after the U.S. market closes on September 22. The…
SKN | Can Aytu BioPharma’s Q4 Results Clarify Its Path Beyond Continued Losses?
  • Ronny Mor
  • •
  • 5 Min Read
  • •
  • 13 hours ago

SKN | Could MillerKnoll’s Q1 Earnings Reveal Whether Margin Pressure Is Temporary?

MillerKnoll is heading into its fiscal first-quarter 2027 earnings release with investors closely watching whether demand and profitability can withstand…
SKN | Could MillerKnoll’s Q1 Earnings Reveal Whether Margin Pressure Is Temporary?
  • omer bar
  • •
  • 5 Min Read
  • •
  • 13 hours ago

SKN | Could AutoZone’s Earnings Report Help the Stock Recover From a 52-Week Low?

AutoZone shares are heading into the company's fiscal fourth-quarter results under pressure after the stock reached a new 52-week low…
SKN | Could AutoZone’s Earnings Report Help the Stock Recover From a 52-Week Low?
  • sagi habasov
  • •
  • 5 Min Read
  • •
  • 23 hours ago

SKN | Could Medicare GLP-1 Coverage Accelerate Eli Lilly’s Obesity Drug Growth?

Medicare Coverage Expands the GLP-1 Market Eli Lilly is seeing significant early demand from Medicare beneficiaries following the launch of…
SKN | Could Medicare GLP-1 Coverage Accelerate Eli Lilly’s Obesity Drug Growth?
  • omer bar
  • •
  • 5 Min Read
  • •
  • 1 day ago

SKN | Can Novo Nordisk’s Post-Wegovy Strategy Restore Investor Confidence?

Novo’s Long-Term Strategy Fails to Calm Investors Novo Nordisk shares came under heavy pressure Monday after the Danish drugmaker unveiled…
SKN | Can Novo Nordisk’s Post-Wegovy Strategy Restore Investor Confidence?
  • Arik Arkadi Sluzki
  • •
  • 5 Min Read
  • •
  • 3 days ago

SKN | Porsche Faces Potential 4,000 Job Cuts as Volkswagen Accelerates Restructuring Plan

  Volkswagen’s restructuring efforts are extending deeper into its premium automotive operations, with Porsche reportedly facing another round of workforce…
SKN | Porsche Faces Potential 4,000 Job Cuts as Volkswagen Accelerates Restructuring Plan
  • Ronny Mor
  • •
  • 5 Min Read
  • •
  • 4 days ago

SKN | Could Rising Oil Prices Trigger a New Global Interest Rate-Hiking Cycle?

Energy Shock Changes the Global Rate Outlook Financial markets are increasingly confronting the possibility of another period of coordinated monetary…
SKN | Could Rising Oil Prices Trigger a New Global Interest Rate-Hiking Cycle?
  • Lior mor
  • •
  • 5 Min Read
  • •
  • 6 days ago

SKN | Can Innate Pharma’s Sobi Partnership Strengthen Its Path Toward Late-Stage Cancer Treatments?

Innate Pharma enters the second half of 2026 with a reshaped financial and development strategy centered on advancing its cancer-immunotherapy…
SKN | Can Innate Pharma’s Sobi Partnership Strengthen Its Path Toward Late-Stage Cancer Treatments?
  • sagi habasov
  • •
  • 5 Min Read
  • •
  • 6 days ago

SKN | Can Microsoft Keep Raising Its Dividend While AI Spending Accelerates?

Microsoft Increases Shareholder Returns Microsoft is raising its quarterly dividend at a time when the technology company is entering an…
SKN | Can Microsoft Keep Raising Its Dividend While AI Spending Accelerates?
  • omer bar
  • •
  • 5 Min Read
  • •
  • 7 days ago

SKN | Can Ispire Technology’s Revenue Growth Offset a Deepening Earnings Loss?

Ispire Technology delivered a mixed fourth-quarter report, combining significantly stronger-than-expected revenue with a substantially larger adjusted loss than analysts had…
SKN | Can Ispire Technology’s Revenue Growth Offset a Deepening Earnings Loss?
  • Lior mor
  • •
  • 6 Min Read
  • •
  • 7 days ago

SKN | Can LuxExperience Sustain Its Turnaround as Investors Await Full-Year 2026 Results?

LuxExperience BV is preparing to report fourth-quarter and full fiscal 2026 results, giving investors another opportunity to assess whether the…
SKN | Can LuxExperience Sustain Its Turnaround as Investors Await Full-Year 2026 Results?
  • Ronny Mor
  • •
  • 5 Min Read
  • •
  • 1 week ago

SKN | Can Bioceres Turn a Difficult Fiscal 2026 Into a Stronger Path for Profitability?

Bioceres Crop Solutions is entering fiscal 2027 after a challenging year in which restructuring, creditor litigation and the reconfiguration of…
SKN | Can Bioceres Turn a Difficult Fiscal 2026 Into a Stronger Path for Profitability?

Hot Spot

Sectors Status

SectorWeight (%)YTD Return
All Sectors100.00%+13.52%
Technology32.58%+22.13%
Financial Services13.31%-0.03%
Industrials10.54%+42.55%
Healthcare9.42%+13.68%
Communication Services9.22%+0.40%
Consumer Cyclical9.03%-4.21%
Energy4.94%+36.38%
Consumer Defensive4.37%+6.23%
Basic Materials2.74%+16.16%
Real Estate2.00%+6.26%
Utilities1.86%+0.86%